[HTML][HTML] Post-transplantation sinusoidal obstruction syndrome in adult patients with B cell acute lymphoblastic leukemia treated with pretransplantation inotuzumab

V Agrawal, H Pourhassan, NC Tsai, D Ngo… - … and Cellular Therapy, 2023 - Elsevier
Sinusoidal obstruction syndrome (SOS) is a potentially life-threatening complication that can
be observed after allogeneic hematopoietic cell transplantation (HCT). Inotuzumab …

Sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic stem cell transplant: insights and therapeutic advances

S Nassereddine, S Alsubait, I Tabbara - Anticancer Research, 2018 - ar.iiarjournals.org
Hepatic sinusoidal obstruction syndrome (SOS) is a rare fatal clinical entity seen following
hematopoietic stem cell transplant (HSCT). It is more commonly reported to occur following …

[HTML][HTML] How can we reduce hepatic veno-occlusive disease–related deaths after allogeneic stem cell transplantation?

DB Johnson, BN Savani - Experimental Hematology, 2012 - Elsevier
Hepatic veno-occlusive disease (VOD) is a common and potentially devastating
complication of hematopoietic stem cell transplantation. Confirmative diagnosis of this …

Veno-occlusive disease in HSCT patients: consensus-based recommendations for risk assessment, diagnosis, and management by the GITMO group

F Bonifazi, S Sica, A Angeletti, S Marktel, A Prete… - …, 2021 - journals.lww.com
Variation in clinical practice affects veno-occlusive disease management, mainly in patients
who undergo allogeneic hematopoietic stem cell transplantation. Disputes about diagnostic …

Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as …

MA Eltelbanei, NA El-Bassiouny, MS Abdalla, M Khalaf… - BMC cancer, 2024 - Springer
Autologous stem cell transplantation (ASCT) is a pivotal treatment for lymphoma patients.
The BeEAM regimen (Bendamustine, Etoposide, Cytarabine, Melphalan) traditionally relies …

[HTML][HTML] Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow …

W Rasheed, A Ghavamzadeh, R Hamladji… - … /oncology and stem cell …, 2013 - Elsevier
Introduction This practice survey is conducted to analyze clinical hematopoietic stem cell
transplantation (HSCT) practice variability among centers in the WHO Eastern …

Hepatic veno‐occlusive disease after taking Gynura Rhizome: The value of multidetector computed tomography in diagnosing the disease and evaluating the clinical …

XW Wu, WQ Wang, B Liu, JM Xu, YQ Yu… - Hepatology …, 2012 - Wiley Online Library
Aim: We conducted this study to evaluate the role of multidetector computed tomography
(MDCT) in diagnosing and differential diagnosis hepatic veno‐occlusive disease (HVOD) …

Management of veno‐occlusive disease: the multidisciplinary approach to care

E Wallhult, M Kenyon, S Liptrott, A Mank… - European journal of …, 2017 - Wiley Online Library
Although it is considered a relatively rare disorder, veno‐occlusive disease (VOD) is one of
the main causes of overall, non‐relapse mortality associated with haematopoietic stem cell …

[HTML][HTML] Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006

K Doney, TA Gooley, HJ Deeg, MED Flowers… - Biology of Blood and …, 2011 - Elsevier
A retrospective analysis identified 161 consecutive adults with acute lymphoblastic leukemia
who underwent allogeneic hematopoietic cell transplantation (HCT) with full-intensity …

Thrombosis and hematopoetic progenitor cells transplant: pathogenesis and most frequent thrombotic complications

WR García, JCJ Fagundo - Revista Cubana de Hematología …, 2015 - medigraphic.com
Thrombotic complications are very common during hematopoietic stem cell transplantation.
The damage to vascular endothelium appears like the triggering factor leading to thrombosis …